Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method

Clinical evidence regarding risk reduction of repeated bladder recurrence after initial photodynamic diagnosis (PDD)-assisted transurethral resection of bladder tumor (TURBT) is still limited in patients with non-muscle-invasive bladder cancer (NMIBC). We analyzed patients with primary NMIBC undergo...

Full description

Bibliographic Details
Main Authors: Makito Miyake, Nobutaka Nishimura, Yasushi Nakai, Tomomi Fujii, Takuya Owari, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Satoshi Anai, Kazumasa Torimoto, Nobumichi Tanaka, Yoshihiko Hirao, Kiyohide Fujimoto
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/2/185
_version_ 1797406512858005504
author Makito Miyake
Nobutaka Nishimura
Yasushi Nakai
Tomomi Fujii
Takuya Owari
Shunta Hori
Yosuke Morizawa
Daisuke Gotoh
Satoshi Anai
Kazumasa Torimoto
Nobumichi Tanaka
Yoshihiko Hirao
Kiyohide Fujimoto
author_facet Makito Miyake
Nobutaka Nishimura
Yasushi Nakai
Tomomi Fujii
Takuya Owari
Shunta Hori
Yosuke Morizawa
Daisuke Gotoh
Satoshi Anai
Kazumasa Torimoto
Nobumichi Tanaka
Yoshihiko Hirao
Kiyohide Fujimoto
author_sort Makito Miyake
collection DOAJ
description Clinical evidence regarding risk reduction of repeated bladder recurrence after initial photodynamic diagnosis (PDD)-assisted transurethral resection of bladder tumor (TURBT) is still limited in patients with non-muscle-invasive bladder cancer (NMIBC). We analyzed patients with primary NMIBC undergoing TURBT without any adjuvant treatment to compare the risk of cumulative recurrence between the conventional white-light (WL)-TURBT and PDD-TURBT. Out of 430 patients diagnosed with primary NMIBC from 2010 to 2019, 40 undergoing WL-TURBT and 60 undergoing PDD-TURBT were eligible. Multivariate Cox regression analysis for time to the first recurrence demonstrated that PDD assistance was an independent prognostic factor with better outcome (<i>p</i> = 0.038, hazard ratio = 0.39, and 95% confidence interval 0.16–0.95). While no patient experienced more than one recurrence within 1000 postoperative days in the PDD-TURBT group, five out of 40 patients treated by WL-TURBT experienced repeated recurrence. The comparison of cumulative incidence per 10,000 person-days between the two groups revealed that PDD assistance decreased by 6.6 recurrences per 10,000 person-days (exact <i>p</i> = 0.011; incidence rate ratio 0.37, Clopper–Pearson confidence interval 0.15–0.82). This is the first study addressing PDD assistance-induced risk reduction of repeated bladder recurrence using the person-time method. Our findings could support clinical decision making, especially on adjuvant therapy after TURBT.
first_indexed 2024-03-09T03:27:32Z
format Article
id doaj.art-930ca7fbd14b4f26aca341a41fb59f4c
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T03:27:32Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-930ca7fbd14b4f26aca341a41fb59f4c2023-12-03T15:00:56ZengMDPI AGDiagnostics2075-44182021-01-0111218510.3390/diagnostics11020185Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time MethodMakito Miyake0Nobutaka Nishimura1Yasushi Nakai2Tomomi Fujii3Takuya Owari4Shunta Hori5Yosuke Morizawa6Daisuke Gotoh7Satoshi Anai8Kazumasa Torimoto9Nobumichi Tanaka10Yoshihiko Hirao11Kiyohide Fujimoto12Department of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Diagnostic Pathology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Prostate Brachytherapy Nara Medical University, Kashihara, Nara 634-8522, JapanDepartment of Urology, Osaka Gyoumeikan Hospital, Konohana-ku, Osaka 554-0012, JapanDepartment of Urology, Nara Medical University, Kashihara, Nara 634-8522, JapanClinical evidence regarding risk reduction of repeated bladder recurrence after initial photodynamic diagnosis (PDD)-assisted transurethral resection of bladder tumor (TURBT) is still limited in patients with non-muscle-invasive bladder cancer (NMIBC). We analyzed patients with primary NMIBC undergoing TURBT without any adjuvant treatment to compare the risk of cumulative recurrence between the conventional white-light (WL)-TURBT and PDD-TURBT. Out of 430 patients diagnosed with primary NMIBC from 2010 to 2019, 40 undergoing WL-TURBT and 60 undergoing PDD-TURBT were eligible. Multivariate Cox regression analysis for time to the first recurrence demonstrated that PDD assistance was an independent prognostic factor with better outcome (<i>p</i> = 0.038, hazard ratio = 0.39, and 95% confidence interval 0.16–0.95). While no patient experienced more than one recurrence within 1000 postoperative days in the PDD-TURBT group, five out of 40 patients treated by WL-TURBT experienced repeated recurrence. The comparison of cumulative incidence per 10,000 person-days between the two groups revealed that PDD assistance decreased by 6.6 recurrences per 10,000 person-days (exact <i>p</i> = 0.011; incidence rate ratio 0.37, Clopper–Pearson confidence interval 0.15–0.82). This is the first study addressing PDD assistance-induced risk reduction of repeated bladder recurrence using the person-time method. Our findings could support clinical decision making, especially on adjuvant therapy after TURBT.https://www.mdpi.com/2075-4418/11/2/185bladder cancerurothelial carcinomatransurethral resectionfluorescencephotodynamic diagnosis5-aminolevulinic acid
spellingShingle Makito Miyake
Nobutaka Nishimura
Yasushi Nakai
Tomomi Fujii
Takuya Owari
Shunta Hori
Yosuke Morizawa
Daisuke Gotoh
Satoshi Anai
Kazumasa Torimoto
Nobumichi Tanaka
Yoshihiko Hirao
Kiyohide Fujimoto
Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method
Diagnostics
bladder cancer
urothelial carcinoma
transurethral resection
fluorescence
photodynamic diagnosis
5-aminolevulinic acid
title Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method
title_full Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method
title_fullStr Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method
title_full_unstemmed Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method
title_short Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method
title_sort photodynamic diagnosis assisted transurethral resection using oral 5 aminolevulinic acid decreases the risk of repeated recurrence in non muscle invasive bladder cancer a cumulative incidence analysis by the person time method
topic bladder cancer
urothelial carcinoma
transurethral resection
fluorescence
photodynamic diagnosis
5-aminolevulinic acid
url https://www.mdpi.com/2075-4418/11/2/185
work_keys_str_mv AT makitomiyake photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT nobutakanishimura photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT yasushinakai photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT tomomifujii photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT takuyaowari photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT shuntahori photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT yosukemorizawa photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT daisukegotoh photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT satoshianai photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT kazumasatorimoto photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT nobumichitanaka photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT yoshihikohirao photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod
AT kiyohidefujimoto photodynamicdiagnosisassistedtransurethralresectionusingoral5aminolevulinicaciddecreasestheriskofrepeatedrecurrenceinnonmuscleinvasivebladdercanceracumulativeincidenceanalysisbythepersontimemethod